Journal of the American Academy of Dermatology
Volume 56, Issue 4 , Pages 621-623 , April 2007

Quality of life impairment in hidradenitis suppurativa: A study of 61 cases

  • Pierre Wolkenstein, MD, PhD

      Affiliations

    • From the Department of Dermatology, Hôpital Henri-Mondor, AP-HP, Paris XII University, Créteil
    • Corresponding Author InformationReprint requests: Pierre Wolkenstein, MD, PhD, Department of Dermatology, Hôpital Henri-Mondor, F-94010 Créteil Cedex, France.
    • ,
  • Anderson Loundou, PhD

      Affiliations

    • Self-Perceived Health Assessment Research Unit, Public Health Department, School of Medicine, Marseille
    • ,
  • Karine Barrau, MD

      Affiliations

    • Self-Perceived Health Assessment Research Unit, Public Health Department, School of Medicine, Marseille
    • ,
  • Pascal Auquier, MD, PhD

      Affiliations

    • Self-Perceived Health Assessment Research Unit, Public Health Department, School of Medicine, Marseille
    • ,
  • Jean Revuz, MD

      Affiliations

    • From the Department of Dermatology, Hôpital Henri-Mondor, AP-HP, Paris XII University, Créteil
    • ,
  • for the Quality of Life Group of the French Society of Dermatology

,Accepted 20 August 2006.

References 

  1. der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14:389–392
  2. der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144:809–813
  3. Jemec GB, Heidenheim M, Nielsen NH. Hidradenitis suppurativa–characteristics and consequences. Clin Exp Dermatol. 1996;21:419–423
  4. Jemec GB, Wulf HC. Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol. 1996;21:177–179
  5. Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149:211–213
  6. Grob JJ, Auquier P, Martin S, Lancon C, Bonerandi JJ. Development and validation of a quality of life measurement for chronic skin disorders in French: VQ-Dermato. Dermatology. 1999;199:213–222
  7. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol. 2001;137:1421–1425
  8. Grob JJ, Revuz J, Ortonne JP, Auquier P, Lorette G. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol. 2005;152:289–295
  9. Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 health survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51:1013–1023
  10. Jemec GB. Effect of localized surgical excisions in hidradenitis suppurativa. J Am Acad Dermatol. 1988;18:1103–1107

 Supported by PHRC 2005 (Hospital Clinical Research Program).Conflicts of interest: None identified.

PII: S0190-9622(06)02359-0

doi: 10.1016/j.jaad.2006.08.061

Journal of the American Academy of Dermatology
Volume 56, Issue 4 , Pages 621-623 , April 2007

Article Tools